bladder cancer Newswire

bladder cancer Newswire

Comprehensive Real-Time News Feed for bladder cancer.

Results 1 - 20 of 663 in bladder cancer

  1. Merck KGaA, Pfizer's cancer drug Bavencio gets EU nodRead the original story w/Photo

    1 hr ago | Channelnewsasia.com

    FRANKFURT: European regulators on Thursday granted market approval for Merck KGaA and Pfizer's immuno-oncology drug Bavencio to treat a rare and aggressive type of skin cancer called Merkel cell carcinoma. In May, Bavencio was approved by the U.S. Food and Drug Administration to treat bladder cancer and in March to treat Merkel cell carcinoma.

    Comment?

  2. Does Diabetes Pose A Cancer Risk? NYP Explains Potential CorrelationRead the original story w/Photo

    17 hrs ago | The Ossining Daily Voice

    ... risk for cancer, as people with the blood disorder are twice as likely to get liver, pancreatic, uterine and bladder cancer, and are up to 50 percent more likely to develop colorectal and breast cancer. Fortunately, reducing the risk for both type 2 ...

    Comment?

  3. UAB Adopts Innovative Imaging Agent to Improve Detection of Certain Bladder CancersRead the original story w/Photo

    18 hrs ago | Newswise

    Bladder cancer is one of the most expensive cancers in the U.S. due to its high rate of recurrence. Newswise - BIRMINGHAM, Ala.

    Comment?

  4. Gallbladder Treatment Market to See Phenomenal Growth of 6.5% by 2023Read the original story w/Photo

    19 hrs ago | SBWire

    ... as gallstones, cholecystitis & biliary colic, cholelithiasis & choledocholithiasis, gallbladder polyps, gall bladder cancer. - On the basis of Diagnosis the market is categorized as ultrasound, blood tests, computerized tomography (CT), ...

    Comment?

  5. DelMar Pharma Announces Issuance Of New Patent On First-In-Class DNA-Targeting Agent, VAL-083Read the original story

    Tuesday | BioSpace

    ... against a range of cancers including central nervous system, ovarian and other solid tumors (e.g. NSCLC, bladder cancer, head & neck) in U.S. clinical trials sponsored by the NCI. Based on DelMar's internal research programs and these prior ...

    Comment?

  6. Natera Selected For Circulating Tumor DNA Study In Bladder CancerRead the original story

    Tuesday | BioSpace

    University to leverage the company's Signatera personalized liquid biopsy technology to evaluate circulating tumor DNA as a useful biomarker in the diagnosis and treatment of bladder cancer. Signatera was recently launched for research use only for oncology researchers and biopharmaceutical companies, and is not for use in diagnostic procedures.

    Comment?

  7. Contrasting Heat Biologics (HTBX) & The CompetitionRead the original story w/Photo

    Tuesday | The Breeze

    ... the Company has developed HS-410 (vesigenurtacel-L) as a product candidate to treat non-muscle invasive bladder cancer (NMIBC), and HS-110 (viagenpumatucel-L), which is intended for use in combination with an anti-PD-1 checkpoint inhibitor, as a ...

    Comment?

  8. This Rosh Hashanah, I Count My BlessingsRead the original story w/Photo

    Tuesday | The Jewish Press

    ... what?" Curious, I looked up the statistics. According to the most recent data, when including all stages of bladder cancer, the 5-year relative survival rate is about 77 percent and the 10-year rate is about 70 percent That's not awful, especially ...

    Comment?

  9. New link seen between gene fusion and bladder cancerRead the original story w/Photo

    Monday Sep 18 | PhysOrg Weblog

    The fibroblast growth factor receptor 3 transforming acidic coiled-coil containing protein 3 gene fusion recruits endogenous TACC3 away from the mitotic spindle, resulting in errors in chromosome segregation in bladder cancer cells, according to a study published online Aug. 30 in Open Biology . Noting that FT3 has been identified in many cancers, including those of the urinary bladder, Sourav Sarkar, Ph.D., from the University of Warwick in the United Kingdom, and colleagues explored potential changes in TACC3 function in FT3-positive cells.

    Comment?

  10. Road hockey helping out in a big wayRead the original story w/Photo

    Monday Sep 18 | Cape Breton Post

    ... while battling illness and wants everyone to be afforded the same comfort. "In May 2014, I was diagnosed with bladder cancer at just 38-years-old," said Gracie, while stepping off the temporary rink. "While I was a patient I got to stay home in my ...

    Comment?

  11. Coronary stent market Size, Share, Mode of Delivery, Material & End User 2021Read the original story

    Monday Sep 18 | Emailwire.com

    ... of urine flow from kidney, in the gall bladder to allow passage of bile in patients suffering from gall bladder cancer, and in the abdomen & gastrointestinal tract. Stents are generally made of metals, polymers, and natural bioabsorbable materials. ...

    Comment?

  12. Nocturia Market: Worldwide Key Industry Segments & Forecast, 2016-2024Read the original story w/Photo

    Friday Sep 15 | SBWire

    ... owing to rise in disposable income, developments in healthcare infrastructure, and increasing incidences of bladder cancer and diabetes conditions. Browse detail report @ Global Nocturia ...

    Comment?

  13. North America Bladder Cancer Therapeutics Market Investment opportunitiesRead the original story

    Friday Sep 15 | Emailwire.com

    North America Bladder Cancer Therapeutics market is expected to reach USD 270.4 million by 2021 from USD 218.3 million in 2016, growing at a CAGR of 4.38% during forecast period 2016-2021. Bladder cancer is aroused due to malignancy of urinary bladder lining with epithelial cells.

    Comment?

  14. Multiple sclerosis: Vitamin D deficiency may predict onsetRead the original story w/Photo

    Thursday Sep 14 | Medical News Today

    ... vitamin D levels are linked with a range of health problems, and researchers have now established a link with bladder cancer. Whilst pointing out that certain groups of the population have deficiencies, the CDC announced in a press release today, ...

    Comment?

  15. Man's bladder stone was almost as big as an ostrich eggRead the original story

    Thursday Sep 14 | Fox News

    ... 6) in The New England Journal of Medicine . The doctors who treated the man noted that he'd had invasive bladder cancer more than a decade before he developed the stones. At the time, surgeons needed to remove his bladder, and they constructed what ...

    Comment?

  16. Latin America Checkpoint Inhibitors market - Industry Analysis,...Read the original story

    Thursday Sep 14 | Emailwire.com

    ... America Checkpoint Inhibitors market by Drug type, by Application (Lung cancer, Renal cancer, Blood cancer, Bladder Cancer, Hodgkin lymphoma, Melanoma, Others), & by Region - Industry Analysis, Share, Size, Growth, Trends, and Forecasts. ( ...

    Comment?

  17. Countdown to Medicine X: An ePatient tackles health care design challengesRead the original story w/Photo

    Wednesday Sep 13 | Stanford

    If there were a rewards or frequent flyer program for time spent in hospitals, I would qualify for an elite status. I lost my first husband to bladder cancer in 2014 after a grueling 11-month quest to save his life.

    Comment?

  18. Asia-Pacific BCG Vaccine Market- Positive Long-Term Growth Outlook 2017-2022Read the original story w/Photo

    Tuesday Sep 12 | PR-inside.com

    ... the national childhood immunization programme. Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the ...

    Comment?

  19. Analyzing Heat Biologics (HTBX) and its CompetitorsRead the original story w/Photo

    Tuesday Sep 12 | AmericanBankingNews.com

    ... the Company has developed HS-410 (vesigenurtacel-L) as a product candidate to treat non-muscle invasive bladder cancer (NMIBC), and HS-110 (viagenpumatucel-L), which is intended for use in combination with an anti-PD-1 checkpoint inhibitor, as a ...

    Comment?

  20. Nektar Initiates PROPEL Clinical Study To Evaluate Combination Of...Read the original story

    Monday Sep 11 | BioSpace

    ... in approved treatment settings of atezolizumab, including patients with non-small cell lung cancer or bladder cancer. The second arm will evaluate an every three-week dose regimen of NKTR-214 in combination with pembrolizumab in up to 30 patients in ...

    Comment?